Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Biora Therapeutics Inc BIOR

Biora Therapeutics, Inc. is a biotechnology company, which is focused on creating smart pills designed for targeted drug delivery to the gastrointestinal (GI) tract, and systemic, needle-free delivery of biotherapeutics. The Company’s pipeline includes two therapeutic delivery platforms: NaviCap and BioJet. The NaviCap, targeted oral delivery platform, which is designed to improve outcomes for... see more

Bullboard (NDAQ:BIOR)

View:
Post by cdogou812on Nov 25, 2021 3:09pm

happy thanksgiving

PROG TO THE MOON SOON !!!
Comment by cdogou812on Nov 16, 2021 11:29am

RE:RE:RE:$4 PRICE TARGET

LETS BOUNCE PROG  LETS GO
Comment by cdogou812on Oct 26, 2021 2:21pm

RE:RE:$4 PRICE TARGET

NOW $5 COMING SOON ! IMO 
Comment by cdogou812on Oct 26, 2021 10:46am

RE:$4 PRICE TARGET

MADE IT TO 4$$$$$$$$$$$$$$
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities